Tvardi Therapeutics, Inc. S-1/A
S-1/A · Tvardi Therapeutics, Inc. · Filed Oct 20, 2025
Documents
- S-1
S-1/A
- EX-23.1
EXHIBIT 23.1
- GRAPHIClg_tvardi-4clr.jpg
GRAPHIC
- GRAPHICtb_pipeline-4c.jpg
GRAPHIC
- GRAPHICph_canonicalfunction-4c.jpg
GRAPHIC
- GRAPHICph_dualmechanism-4c.jpg
GRAPHIC
- GRAPHICph_fibroticcascade-4c.jpg
GRAPHIC
- GRAPHICph_indsubmission-4c.jpg
GRAPHIC
- GRAPHICph_majorcompartments-4clr.jpg
GRAPHIC
- GRAPHICph_lungfibrosis-4clr.jpg
GRAPHIC
- GRAPHICbc_impactonboth-4c.jpg
GRAPHIC
- GRAPHICbc_demonstrateddose-4c.jpg
GRAPHIC
- GRAPHICfc_ipftherapies-4clr.jpg
GRAPHIC
- GRAPHICfc_phase2clinical-4c.jpg
GRAPHIC
- GRAPHICph_nashinduced-4clr.jpg
GRAPHIC
- GRAPHICph_hccpdxtumor-4clr.jpg
GRAPHIC
- GRAPHICph_tumortrajectories-4c.jpg
GRAPHIC
- GRAPHICfc_phase1clinical-4c.jpg
GRAPHIC